Q1 2015 13F Holders as of 3/31/2015
-
Type / Class
-
Equity / COM
-
Number of holders
-
86
-
Total 13F shares, excl. options
-
29.2M
-
Shares change
-
+4.49M
-
Total reported value, excl. options
-
$494M
-
Value change
-
+$76.7M
-
Put/Call ratio
-
1.02
-
Number of buys
-
59
-
Number of sells
-
-31
-
Price
-
$16.94
Significant Holders of REGULUS THERAPEUTICS INC - COM (RGLS) as of Q1 2015
108 filings reported holding RGLS - REGULUS THERAPEUTICS INC - COM as of Q1 2015.
REGULUS THERAPEUTICS INC - COM (RGLS) has 86 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.2M shares
.
Largest 10 shareholders include FMR LLC (7.58M shares), WELLINGTON MANAGEMENT GROUP LLP (5.41M shares), Capital World Investors (2.49M shares), STATE STREET CORP (1.36M shares), ORACLE INVESTMENT MANAGEMENT INC (1.29M shares), UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (1.1M shares), BlackRock Fund Advisors (1.06M shares), Cormorant Asset Management, LLC (897K shares), VANGUARD GROUP INC (847K shares), and GOLDMAN SACHS GROUP INC (803K shares).
This table shows the top 86 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.